I have looked at trade statistics on three projects from the point of view of token cost. Unfortunately, today all of them trade low prices of their primary placement. However in January, along with the general growth, MediBloc has grown very well. From the positive moments I can note the fact that the websites of these projects regularly publish news and there are no prerequisites to call them swindlers.